N. A. Gorbachev

N. A. Gorbachev

Auto-generated profile, based on publicly available information

N. A. Gorbachev

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2024 in Russian Journal of Pain
Verified
Journal Article
Closed access
ARA.V. Romanenko
A.V. Romanenko
VMV.V. Murzo
V.V. Murzo
KPK.A. Popovskaya
K.A. Popovskaya
ESE.G. Seliverstova
E.G. Seliverstova
NGN.A. Gorbachev
N.A. Gorbachev
OTOybek Erkin ugli Turgunkhujaev
Oybek Erkin ugli Turgunkhujaev
Migraine is one of the most common neurological diseases manifested by headache attacks. Calcitonin-gene related peptide (CGRP) plays a key role in the pathophysiology of migraine. The release of CGRP during a migraine attack leads to cranial vasodilation and neurogenic inflammation. As a result, the sensory fibres of the trigeminal nerve become activated and the transmission of pain impulses to the brain is modulated. Due to the wide representation of CGRP receptors in the brain, the calcitonin-gene related peptide is an actively studied target in studies of antimigraine drugs. This review presents the mechanisms of action, a description of the structure, receptors of the calcitonin gene-related peptide in the pathophysiology of migraine and demonstrates new therapeutic options related to CGRP.

15 May 2025 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
IZI.M. Zavalko
I.M. Zavalko
MPMikhail Poluektov
Mikhail Poluektov
PPPolina Pchelina
Polina Pchelina
MBMikhail Bochkarev
Mikhail Bochkarev
RBR.V. Buzunov
R.V. Buzunov
EYE.Z. Yakupov
E.Z. Yakupov
This consensus was developed to establish the terms, basic concepts, and approaches of non-drug treatment of chronic insomnia — cognitive-behavioral therapy of insomnia (CBT-I). The text captures the view of the professional community that both clinical psychologists and psychotherapists, as well as doctors of various specializations with experience in the diagnosis and treatment of sleep disorders, can use CBT-I with the knowledge and skills listed in the relevant section. Indications and contraindications are also listed, and a brief description of behavioral and cognitive techniques, as well as a standard CBT-I protocol, is provided, while the possibility of deviations from it in specific clinical situations is clearly emphasized. The specifics of the method application in special populations and possible therapy formats are also considered.

11 April 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
NGN. A. Gorbachev
N. A. Gorbachev
MPMikhail Poluektov
Mikhail Poluektov
The role in the body and the biological significance of the pineal hormone melatonin is discussed. Data are presented on the effect on biological rhythms in humans and animals, as well as on the sleep in general. In diurnal humans and animals, melatonin acts on the suprachiasmatic nuclei of the hypothalamus to dampen the wake-stimulating signal of the internal clock, thereby promoting sleep. Data are presented on the clinical use of melatonin in sleep disorders: Circadian Rhythm Sleep-Wake Disorders (jet lag syndrome, delayed sleep phase syndrome, irregular cycle), parasomnias (Rapid-Eye Movements Sleep Behavior Disorder) and insomnia. A significant effect of melatonin preparations with a high level of evidence was confirmed in Circadian Rhythm Sleep-Wake Disorders, less pronounced in Parasomnias. The effects of melatonin, used as a drug for jet lag, have the greatest degree of evidence. The melatonin preparation is recommended to be taken both before the flight and at the new place of stay in accordance with the time of its evening secretion in this time zone. In delayed sleep phase syndrome, the onset of melatonin secretion is delayed, reflecting a general lag in the body’s internal clock. Taking melatonin preparations leads to a shift in the sleep-wake cycle to an earlier time. In REM sleep behavior disorder, melatonin preparations to reduce excessive motor activity are preferred over benzodiazepines, since this disorder manifests itself in people of older age groups, and an undesirable effect on cognitive functions should be avoided. In chronic insomnia, the effect of melatonin significantly exceeds the placebo effect and is most pronounced in people of older age groups.

1 November 2025 in Neuroscience and Behavioral Physiology
Verified
Journal Article
Closed access
PDF file
MZM. V. Zhuravleva
M. V. Zhuravleva
ELE. V. Luchinina
E. V. Luchinina
NGN. A. Gorbachev
N. A. Gorbachev
MPM. G. Poluektov
M. G. Poluektov

21 June 2024 in Neurology, Neuropsychiatry, Psychosomatics
Verified
Journal Article
Open access
PDF file
NGN. A. Gorbachev
N. A. Gorbachev
AOA. V. Obukhova
A. V. Obukhova
LFL. A. Fedeneva
L. A. Fedeneva
MPMikhail Poluektov
Mikhail Poluektov
Anxiety and depressive disorders are common in restless legs syndrome (RLS); in some cases, the disease is accompanied by cognitive impairment and a deterioration in quality of life. The most important treatment method for RLS is the use of dopaminergic medications. In some cases, the use of these drugs leads to a complication - the phenomenon of augmentation, which manifests itself in an increase in RLS symptoms as the dose of medication increases.Objective: to determine the clinical and neurophysiological characteristics of RLS patients with the augmentation phenomenon.Material and methods. 40 patients with RLS were examined: 20 with augmentation (main group, MG; 5 men and 15 women) and 20 without augmentation (comparison group, CG; 7 men and 13 women). The median age of the patients in the MG was 63.5 [56; 71] years, and 62.0 [43.5; 71.5] years in the CG. Clinical assessment was performed using the RLS Severity Rating Scale (RS), Montreal Cognitive Assessment Scale (MoCA), Beck Anxiety Inventory, Beck Depression Inventory, Quality of Life Scale (SF-36), Insomnia Severity Index (ISI), Trail Making Test (Part A), Trail Making Test (part B), phonemic and semantic speech activity tests. All patients underwent suggested immobilization test (SIT) to assess the urge to move on a 10-point numerical rating scale (NRS) and periodic limb movements (PLM) while awake, as well as a polysomnographic examination.Results. Augmentation significantly more frequently resulted in an expansion of the area of distribution of the urge to move and other unpleasant sensations over the entire surface of the legs (p=0.01), painful discomfort in the legs (p=0.001), early onset of symptoms (04:00—18:00; p=0.04), shortening of the latency period for the onset of symptoms (p=0.001), twitching in the legs while awake (p=0.04), taking higher doses of dopaminergic medications (p=0.004). In augmentation, the MoCA score is lower (p=0.01), such patients use fewer words in the semantic speech activity test (p=0.049), have a higher score on the RS (p=0.001) and ISI (p=0.02), a greater number of PLMs while awake according to SIT (p=0.01) compared to CG. No significant differences were found between groups in terms of age, gender, ferritin level, total score on the Beck Anxiety and Depression Inventory, SF-36 Quality of Life Scale, Trail Making Test (Part A), Trail Making Test (part B), phonemic speech activity test, polysomnography indicators (including motor activity during sleep).Conclusion. From a clinical and neurophysiological point of view, the phenomenon of augmentation is not simply a manifestation of a more severe course of RLS but has features that reflect the pathogenesis of this disorder. During augmentation, patients tend to describe the sensations as painful and their involuntary motor activity increases. This reflects changes in the activity of the diencephalospinal tract due to excessive dopaminergic stimulation.

8 March 2017 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
PDF file
LMLarisa Maltseva
Larisa Maltseva
OMOlga Leonidovna Morozova
Olga Leonidovna Morozova
NGN. A. Gorbachev
N. A. Gorbachev
PLP. F. Litvitskiy
P. F. Litvitskiy
The review is dedicated to the investigation of the role of A.B. Fokht, who was one of the most famous scientist, teacher and doctor during the period of the development of clinical oriented approach pathophysiology. The article examines new vectors in clinical medicine development of the second half of the 19th century. It is pointed out in the article that Russian scientists of that time instead of aiming at history rewriting or repeating the traditions of the West-European science finally formed their own rational ideas and tried to provide unique scientific research. What is more, the article contains biographical information about Fokht’s family, his teachers and colleagues. The article describes the main principles of Fokht’s scientific school, which became the most remarkable in Russia in the beginning of the 20th century, and also achievements of his followers, who had been working in the largest laboratories and chairs of Great Britain, the USA, Poland etc. Moreover the article contains information about the influence which the results of Fokht’s research had on recognition of Russian independent medical science worldwide. The article emphasizes the Fokht’s political and civil position against the educational and scientific reforms, which had been conducted by the Russian government in the beginning of the 20th century. Finally, the article describes Fokht’s personality and his activities in other spheres.